Results 251 to 260 of about 50,964 (281)
Some of the next articles are maybe not open access.
Novel treatments for castration-resistant prostate cancer
European Journal of Cancer, 2011The contemporary management of metastatic castration-resistant prostate cancer (mCRPC) is evolving dramatically. Understanding the biology of this disease, positive phase III studies and approvals for 4 novel agents in the US in 2010 and shortly in Europe have dramatically changed the therapeutic landscape.
openaire +2 more sources
Denosumab in castration-resistant prostate cancer
The Lancet, 2012Athanassios, Kyrgidis +1 more
openaire +2 more sources
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine, 2021Oliver Sartor +2 more
exaly
Current therapy and drug resistance in metastatic castration-resistant prostate cancer
Drug Resistance Updates, 2023Maoping Cai +2 more
exaly
Metastatic castrate-resistant prostate cancer
Urologic Oncology: Seminars and Original Investigations, 2015openaire +2 more sources
Clinical development of novel therapeutics for castration‐resistant prostate cancer
Ca-A Cancer Journal for Clinicians, 2012Matthew D Galsky +2 more
exaly